SCHEMBL7797567

SCHEMBL7797567

CCOC(=O)C(CC(=O)c1ccc(OC)c(OC)c1)(NC=O)C(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
CYP2C19 P33261 2/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 6/20 0.47
TSHR P16473 3/20 0.47
CTNNB1 P35222 2/20 0.47
WNT3A P56704 2/20 0.47
KDM4E B2RXH2 3/20 0.45
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
GAA P10253 2/20 0.44
PDE4B Q07343 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8654336 0.94 ALDH1A1 (0.45) ALDH1A1CYP2C19POLBMAPTTSHR
SCHEMBL7801959 0.84 ALDH1A1 (0.58) ALDH1A1CYP2C19POLBMAPTLMNA
SCHEMBL7799507 0.82 CHRM2 (0.47) ALDH1A1POLBMAPTTSHRKDM4E
SCHEMBL7797583 0.82 ALDH1A1 (0.43) ALDH1A1POLBMAPTTSHRMEN1
SCHEMBL7797586 0.82 MAPT (0.45) ALDH1A1MAPTTSHRKDM4ELMNA
SCHEMBL7801964 0.81 SMN1; SMN2 (0.48) ALDH1A1POLBTSHRKDM4EMAPK1
SCHEMBL7802020 0.81 MEN1 (0.46) ALDH1A1MAPTTSHRKDM4ELMNA
SCHEMBL7800771 0.81 NPSR1 (0.42) ALDH1A1POLBMAPTCTNNB1WNT3A
SCHEMBL7800741 0.80 ALDH1A1 (0.44) ALDH1A1CYP2C19POLBMAPTKDM4E
SCHEMBL7799487 0.80 ALDH1A1 (0.49) ALDH1A1CYP2C19POLBMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT ALDH1A1 615/4885CYP2C19 345/4885POLB 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.